skip to main content

"Re: Energie für morgen"

Lars Angenent, Professor of Environmental Biotechnology at the University of Tübingen and CMFI Principal Investigator, was interviewed for the ARTE broadcast "Re: Energie für morgen".

11.11.2022 In the Media

In the documentary, Lars Angenent gives an insight into his research work in Tübingen and explains how he uses wind power to convert harmful CO2 from the atmosphere into renewable methane gas that can be fed directly into the gas grid.

The greenhouse gas CO2 produced by humans is considered one of the main causes of climate change. Angenent's innovation contributes to solving this problem. CO2 is used as a building block for methane production using bacteria. His vision of sustainable production of biogas such as methane, is particularly relevant now in the wake of the climate crisis and for supply independence from imported gas.

He says, "If we really want it, we can do it. The technology is ready, but we have to be fast."

You can find the complete broadcast in the ARTE media library.

Under the title "Clever in die Zukunft: Alternativen für die Energiewende", it was also on ZDF's plan b broadcast. Go to ZDF media library (only German)

 

 

Scientific Contact

Prof. Dr. Ir.  Largus  T.  Angenent

University of Tübingen
Zentrum für Angewandte Geowissenschaften
Umweltbiotechnologie

l.angenent@uni-tuebingen.de

Website

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

 

Related Articles

Volkswagen Foundation funds project to convert waste into new biomaterials
14.02.2024 Volkswagen Foundation funds project to convert waste into new biomaterials CMFI News
Exploring hidden members in microbial communities
05.02.2024 Exploring hidden members in microbial communities CMFI News
Antibiotics highjack bacterial immunity
19.01.2024 Antibiotics highjack bacterial immunity Press Release
Novel antibiotic substance from the human nose
18.12.2023 Novel antibiotic substance from the human nose Press Release
The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future
30.11.2023 The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future In the Media

Nature - Behind the paper

Taking antibiotics back in time
30.11.2023 Taking antibiotics back in time Press Release
Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie?
23.11.2023 Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie? Press Release
Andreas Peschel at Deutschlandfunk Kultur “Zeitfragen” Podcast
16.11.2023 Andreas Peschel at Deutschlandfunk Kultur “Zeitfragen” Podcast In the Media

Deutschlandfunk Kultur

“Wie unsere Nase unsere Immunantwort beeinflusst”
04.11.2023 “Wie unsere Nase unsere Immunantwort beeinflusst” In the Media

radioeins/RBB

Unique nasal microbiome
25.10.2023 Unique nasal microbiome Press Release
CRISPR maps temperature-sensitive mutations in E. coli
12.10.2023 CRISPR maps temperature-sensitive mutations in E. coli CMFI News
New study advocates remission as therapeutic goal in prediabetes
26.09.2023 New study advocates remission as therapeutic goal in prediabetes Press Release
Potatos with the right antennae
06.09.2023 Potatos with the right antennae Press Release
Lukas Mager receives ERC Starting Grant
05.09.2023 Lukas Mager receives ERC Starting Grant Press Release
Biosurfactants might offer an environmentally friendly solution for tackling oil spills
21.07.2023 Biosurfactants might offer an environmentally friendly solution for tackling oil spills Press Release
Science2Start competition: First place for CMFI PIs
14.07.2023 Science2Start competition: First place for CMFI PIs Press Release
Khaled Selim receives FEMS Outstanding Early Career Microbiologist Award
12.07.2023 Khaled Selim receives FEMS Outstanding Early Career Microbiologist Award CMFI News
Thorsten Nürnberger elected EMBO member
04.07.2023 Thorsten Nürnberger elected EMBO member Press Release